Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Hampshire Health Report.
Press releases published on May 27, 2025
Aja Health and Wellness Inc. Announces Launch of Nasal Product for Migraine Headache Relief and Provides Update on Delay in Filing Financial Statements
GlobeNewswire
·
May 27, 2025
Not for dissemination in the United States of America VANCOUVER, British Columbia, May 27, 2025 (GLOBE NEWSWIRE) -- Aja Health and Wellness Inc. ("Aja" or the "Company") (TSXV:Aja) announces that its wholly owned subsidiary Aja Therapeutics Inc. ("ATI") is …
Jamieson Wellness Inc. Announces Voting Results from 2025 Annual Meeting of Shareholders
GlobeNewswire
·
May 27, 2025
TORONTO, May 27, 2025 (GLOBE NEWSWIRE) -- Jamieson Wellness Inc. (“Jamieson Wellness” or the “Company”) (TSX: JWEL) announced today that each of the nominee directors listed in the management information circular of the Company dated March 10, 2025 was …
Yerbaé Partners with National Foodservice Provider, Guckenheimer
GlobeNewswire
·
May 27, 2025
New partnership brings Yerbaé’s functional beverages to Guckenheimer’s national café …
Aptose Announces Results from Annual and Special Meeting of Shareholders
GlobeNewswire
·
May 27, 2025
SAN DIEGO and TORONTO, May 27, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. ("Aptose" or the "Company") (TSX: APS; OTC: APTOF), a clinical-stage precision oncology company developing a tuspetinib (TUS) based triple drug frontline therapy to treat …
Extendicare Announces Voting Results for its 2025 Annual and Special Meeting of Shareholders
GlobeNewswire
·
May 27, 2025
MARKHAM, Ontario, May 27, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today announced the results of matters voted on at its annual and special meeting of shareholders held on May 27, 2025 (the “Meeting”). The …
Teva Celiac Disease Candidate Granted Fast Track Designation by US FDA
GlobeNewswire
·
May 27, 2025
Fast Track designation granted for investigational TEV-53408, an anti-IL-15 antibody Designation underscores the potential of TEV-53408, currently undergoing a Phase 2a study for the treatment of celiac disease Candidate demonstrates Teva’s commitment to …
INVO Fertility to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025
GlobeNewswire
·
May 27, 2025
SARASOTA, Fla., May 27, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare services fertility company focused on expanding access to advanced treatment through the establishment, acquisition and …
ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
GlobeNewswire
·
May 27, 2025
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, May 27, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced …
ANI Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference
GlobeNewswire
·
May 27, 2025
PRINCETON, N.J., May 27, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, will present at the 2025 Jefferies Global Healthcare Conference in New York City …
Precision Optics to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025
GlobeNewswire
·
May 27, 2025
GARDNER, Mass., May 27, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced it …
Dentsply Sirona Declares Quarterly Cash Dividend
GlobeNewswire
·
May 27, 2025
CHARLOTTE, N.C., May 27, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) announced that its Board of Directors declared a quarterly cash dividend of $0.16 per share of common stock, an indicated annual rate …
Neuphoria to Present at the American Society of Clinical Psychopharmacology (ASCP) 2025 Annual Meeting
GlobeNewswire
·
May 27, 2025
BURLINGTON, Mass., May 27, 2025 (GLOBE NEWSWIRE) -- Neuphoria Therapeutics Inc. (Nasdaq: NEUP) (“Neuphoria” or the “Company”), a clinical-stage biotechnology company developing impactful treatments for neuropsychiatric disorders, today announced an …
Assembly Biosciences to Present During the Jefferies 2025 Global Healthcare Conference
GlobeNewswire
·
May 27, 2025
SOUTH SAN FRANCISCO, Calif., May 27, 2025 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral diseases, today announced that Jason Okazaki, chief executive …
Myriad Genetics Highlights New Research Advancements and Oncology Innovations at 2025 ASCO Annual Meeting
GlobeNewswire
·
May 27, 2025
SALT LAKE CITY, May 27, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announced it will share data from seven new research studies at the 2025 ASCO Annual Meeting, including …
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
GlobeNewswire
·
May 27, 2025
Company announcement – No. 13 / 2025 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, May 27, 2025 – Zealand Pharma A/S ("the …
Inventiva to Participate in the Upcoming Jefferies Global Healthcare Conference and UBS Spring Biotech Conference
GlobeNewswire
·
May 27, 2025
Daix (France), New York City (New York, United States), May 27, 2025 – Inventiva (Euronext Paris and NASDAQ: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of …
Dr. Jeremy Saul Announces National Scholarship Initiative to Support Aspiring Medical Students Pursuing Careers in Healthcare
GlobeNewswire
·
May 27, 2025
RUSSELLVILLE, Ark., May 27, 2025 (GLOBE NEWSWIRE) -- The Dr. Jeremy Saul Scholarship for Medical Students is now officially open for applications, offering aspiring undergraduate students across the United States the opportunity to receive a one-time award …
Dr. David Webb Launches National Scholarship Initiative to Support Aspiring Healthcare Professionals with a Vision to Serve
GlobeNewswire
·
May 27, 2025
PACATELLO, Idaho, May 27, 2025 (GLOBE NEWSWIRE) -- The Dr. David Webb Scholarship for Future Doctors is now accepting applications from students across the United States who are dedicated to building careers in healthcare. Spearheaded by Dr. David Webb, …
Scientific Industries to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025
GlobeNewswire
·
May 27, 2025
BOHEMIA, N.Y., May 27, 2025 (GLOBE NEWSWIRE) -- Scientific Industries, Inc. (OTCQB: SCND), a life sciences tool provider, and a developer of digitally simplified bioprocessing products, announced it will participate in a webcast presentation and host one- …
Leading Independent Proxy Advisory Firm Glass Lewis Recommends Stockholders Vote “FOR” All of Keros’ Director Nominees
GlobeNewswire
·
May 27, 2025
Keros Board Best Equipped to Oversee Strategic Review Process and Execute on Ultimate Outcome of that Process ADAR1’s Disruptive and Self-Serving Campaign Stands to Jeopardize the Future Value Maximizing Potential of the Company Keros Urges Stockholders to …